U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Type (AI-Driven Engagement, Telehealth Solutions), By Delivery Type (Web/Cloud-based, On-premise), By Functionality, By End Use, By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Patient Engagement Solutions Market Growth & Trends
The U.S. patient engagement solutions market size is anticipated treach USD 22.41 billion in 2030 and is expected tgrow at a CAGR of 19.77% from 2025 t2030, according ta new report by Grand View Research, Inc. The key factors driving the market growth include rising digitalization in healthcare, the prevalence of chronic conditions, adoption by patients, and the COVID-19 pandemic.
The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians thave rapid and full access ta patient's history tmake the best-informed decision about their care. This propelled the growth of the market.
For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems, and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021. A large population over the age of 60 is a key driver for the U.S. patient engagement solutions market. This is owing tlower immunity levels in the geriatric population and higher vulnerability tchronic conditions such as obesity, cardiac problems, and cancer.
In fact, as per the U.S. Census Bureau, the median age of the country’s population is estimated treach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely tavail the best possible treatments tincrease life span. The incidence of chronic illnesses in the U.S. is alson the rise despite the availability of several effective therapies. The incidence of chronic illnesses in the U.S. is alson the rise despite the availability of several effective therapies.
Chronic ailments are the leading cause of disability & death and are the leading drivers of the country’s USD 3.8 trillion 12-monthly healthcare costs, according tthe CDC. The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but alsessential. Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks, and emerging 5G technology, are rapidly boosting the use of mobile health.
Furthermore, there has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading tthe progress of mobile health solutions. The usage of mobile applications has proven tbe very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers, and maintaining health records. This is expected tfuel the market growth.
U.S. Patient Engagement Solutions Market Report Highlights
U.S. Patient Engagement Solutions Market Growth & Trends
The U.S. patient engagement solutions market size is anticipated treach USD 22.41 billion in 2030 and is expected tgrow at a CAGR of 19.77% from 2025 t2030, according ta new report by Grand View Research, Inc. The key factors driving the market growth include rising digitalization in healthcare, the prevalence of chronic conditions, adoption by patients, and the COVID-19 pandemic.
The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians thave rapid and full access ta patient's history tmake the best-informed decision about their care. This propelled the growth of the market.
For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems, and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021. A large population over the age of 60 is a key driver for the U.S. patient engagement solutions market. This is owing tlower immunity levels in the geriatric population and higher vulnerability tchronic conditions such as obesity, cardiac problems, and cancer.
In fact, as per the U.S. Census Bureau, the median age of the country’s population is estimated treach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely tavail the best possible treatments tincrease life span. The incidence of chronic illnesses in the U.S. is alson the rise despite the availability of several effective therapies. The incidence of chronic illnesses in the U.S. is alson the rise despite the availability of several effective therapies.
Chronic ailments are the leading cause of disability & death and are the leading drivers of the country’s USD 3.8 trillion 12-monthly healthcare costs, according tthe CDC. The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but alsessential. Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks, and emerging 5G technology, are rapidly boosting the use of mobile health.
Furthermore, there has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading tthe progress of mobile health solutions. The usage of mobile applications has proven tbe very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers, and maintaining health records. This is expected tfuel the market growth.
U.S. Patient Engagement Solutions Market Report Highlights
- The U.S. market experienced high levels of innovation, driven by advancements in AI, machine learning, and telemedicine. For instance, in August 2024, Press Ganey, a healthcare provider of experience measurement and data analytics, announced an expansion of its PX Connect Suite, allowing healthcare organizations tcapture and respond tpatient feedback directly within Epic
- The AI-driven engagement segment held the largest revenue share of 30.54% in 2024 and is anticipated texpand at the fastest CAGR due tits ability tpersonalize care and enhance patient-provider interactions
- The web/cloud-based segment dominated the market in 2024 with a revenue share of 67.38% and is anticipated texpand at the fastest CAGR. Factors include the growing adoption of telehealth, increased demand for remote patient monitoring, and the shift tvalue-based care models
- The enhanced communication segment held the largest revenue share in 2024. With the increasing adoption of AI-driven solutions in healthcare, the demand for advanced communication capabilities is growing
- The healthcare providers segment held the largest revenue share in 2024. Providers handle the highest number of patients and serve as the main point of contact for a wide range of health issues, from general tspecialized care, and are the primary adopters of patient engagement solutions
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective -
1.8.2. Objective -
1.8.3. Objective -
1.9. List of Secondary Sources
1.10. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. U.S. Patient Engagement Solutions Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Types segment outlook
2.1.2.2. Delivery type segment outlook
2.1.2.3. Functionality segment outlook
2.1.2.4. End Use segment outlook
2.1.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Shift toward patient-centered care
3.3.1.2. Growing need to curb rising healthcare costs
3.3.1.3. Rising initiatives by organizations
3.3.1.4. The emergence of digital platforms and necessity for omnichannel approach
3.3.2. Market Restraint Analysis
3.3.2.1. Data privacy and ethical considerations
3.3.2.2. Lack of Interoperability Among Healthcare Providers
3.3.3. Market Opportunity Analysis
3.3.4. Market Challenges Analysis
3.4. Case Studies
3.5. Regulatory Framework
3.5.1. Industry Analysis - Porter’s Five Forces Analysis:- Pharmacy
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. Porter’s five forces analysis
3.5.3. PEST Analysis by Factors (Political & Legal, Economic, Social, and Technology)
3.5.4. COVID-19 Impact Analysis
CHAPTER 4. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. U.S. Patient Engagement Solutions Market: Type Movement Analysis
4.2. U.S. Patient Engagement Solutions Market: Type Segment Dashboard
4.3. Type Movement & Market Share Analysis, 2024 & 2030
4.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Type
4.5. AI-Driven Engagement
4.5.1. AI-driven engagement market, 2018 - 2030 (USD Million)
4.6. Telehealth Solutions
4.6.1. Telehealth Solutions market, 2018 - 2030 (USD Million)
4.7. Patient Portals
4.7.1. Patient Portals market, 2018 - 2030 (USD Million)
4.8. Remote Patient Monitoring
4.8.1. Remote Patient Monitoring market, 2018 - 2030 (USD Million)
4.9. Population Health Management
4.9.1. Population Health Management market, 2018 - 2030 (USD Million)
4.10. Appointment and Medication Reminders
4.10.1. Appointment and Medication Reminders market, 2018 - 2030 (USD Million)
4.11. Others
4.11.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: DELIVERY TYPE ESTIMATES & TREND ANALYSIS
5.1. U.S. Patient Engagement Solutions Market: Delivery Type Movement Analysis
5.2. U.S. Patient Engagement Solutions Market: Delivery Type Segment Dashboard
5.3. Delivery Type Movement & Market Share Analysis, 2024 & 2030
5.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Delivery Type
5.5. Web/Cloud-Based
5.5.1. Web/cloud-based market, 2018 - 2030 (USD Million)
5.6. On-premise
5.6.1. On-premise market, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
6.1. U.S. Patient Engagement Solutions Market: Functionality Movement Analysis
6.2. U.S. Patient Engagement Solutions Market: Functionality Segment Dashboard
6.3. Functionality Movement & Market Share Analysis, 2024 & 2030
6.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Functionality
6.5. Enhanced Communication
6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.6. Patient Education
6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.7. Predictive Analysis
6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.8. Streamlined Operations
6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. U.S. Patient Engagement Solutions Market: End Use Movement Analysis
7.2. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
7.3. End Use Movement & Market Share Analysis, 2024 & 2030
7.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by End Use
7.5. Healthcare Providers
7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.5.2. Outpatient Facility
7.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.5.3. Inpatient Facility
7.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6. Healthcare Payers
7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6.2. Private
7.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6.3. Public
7.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.7. Pharmaceutical Companies (Pharma)
7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8. Pharmacy
7.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.2. Independent Pharmacies (Nuclear Pharmacies)
7.8.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.3. Community Pharmacies
7.8.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.4. Mail-Order Pharmacies
7.8.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.5. Retail Pharmacies
7.8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.6. Digital Pharmacies
7.8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.7. Specialty Pharmacies
7.8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.8. Central Fill Pharmacies
7.8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.9. Compounding Pharmacies
7.8.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.10. Others (Alternate dispensing site, Closed door)
7.8.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company Categorization
8.2. Company Market Position Analysis
8.3. Company Share Analysis
8.3.1. Partnership/Collaboration/Alliance
8.3.2. New Service Launch
8.3.3. Mergers & Acquisitions
8.3.4. Others
8.4. Company Profiles/Listing
8.4.1. Cerner Corporation (Oracle)
8.4.1.1. Overview
8.4.1.2. Financial performance
8.4.1.3. Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. NextGen Healthcare, Inc.
8.4.2.1. Overview
8.4.2.2. Financial performance
8.4.2.3. Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Epic Systems Corporation
8.4.3.1. Overview
8.4.3.2. Financial performance
8.4.3.3. Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Allscripts Healthcare, LLC
8.4.4.1. Overview
8.4.4.2. Financial performance
8.4.4.3. Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. McKesson Corporation
8.4.5.1. Overview
8.4.5.2. Financial performance
8.4.5.3. Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. ResMed
8.4.6.1. Overview
8.4.6.2. Financial performance
8.4.6.3. Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Koninklijke Philips N.V.
8.4.7.1. Overview
8.4.7.2. Financial performance
8.4.7.3. Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Klara Technologies, Inc.
8.4.8.1. Overview
8.4.8.2. Financial performance
8.4.8.3. Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. CPSI, Ltd.
8.4.9.1. Overview
8.4.9.2. Financial performance
8.4.9.3. Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Experian Information Solutions, Inc.
8.4.10.1. Overview
8.4.10.2. Financial performance
8.4.10.3. Service benchmarking
8.4.10.4. Strategic initiatives
8.4.11. athenahealth
8.4.11.1. Overview
8.4.11.2. Financial performance
8.4.11.3. Service benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Solutionreach, Inc.
8.4.12.1. Overview
8.4.12.2. Financial performance
8.4.12.3. Service benchmarking
8.4.12.4. Strategic initiatives
8.4.13. IBM
8.4.13.1. Overview
8.4.13.2. Financial performance
8.4.13.3. Service benchmarking
8.4.13.4. Strategic initiatives
8.4.14. MEDHOST
8.4.14.1. Overview
8.4.14.2. Financial performance
8.4.14.3. Service benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Nuance Communications, Inc.
8.4.15.1. Overview
8.4.15.2. Financial performance
8.4.15.3. Service benchmarking
8.4.15.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective -
1.8.2. Objective -
1.8.3. Objective -
1.9. List of Secondary Sources
1.10. List of Secondary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. U.S. Patient Engagement Solutions Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Types segment outlook
2.1.2.2. Delivery type segment outlook
2.1.2.3. Functionality segment outlook
2.1.2.4. End Use segment outlook
2.1.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Shift toward patient-centered care
3.3.1.2. Growing need to curb rising healthcare costs
3.3.1.3. Rising initiatives by organizations
3.3.1.4. The emergence of digital platforms and necessity for omnichannel approach
3.3.2. Market Restraint Analysis
3.3.2.1. Data privacy and ethical considerations
3.3.2.2. Lack of Interoperability Among Healthcare Providers
3.3.3. Market Opportunity Analysis
3.3.4. Market Challenges Analysis
3.4. Case Studies
3.5. Regulatory Framework
3.5.1. Industry Analysis - Porter’s Five Forces Analysis:- Pharmacy
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. Porter’s five forces analysis
3.5.3. PEST Analysis by Factors (Political & Legal, Economic, Social, and Technology)
3.5.4. COVID-19 Impact Analysis
CHAPTER 4. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. U.S. Patient Engagement Solutions Market: Type Movement Analysis
4.2. U.S. Patient Engagement Solutions Market: Type Segment Dashboard
4.3. Type Movement & Market Share Analysis, 2024 & 2030
4.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Type
4.5. AI-Driven Engagement
4.5.1. AI-driven engagement market, 2018 - 2030 (USD Million)
4.6. Telehealth Solutions
4.6.1. Telehealth Solutions market, 2018 - 2030 (USD Million)
4.7. Patient Portals
4.7.1. Patient Portals market, 2018 - 2030 (USD Million)
4.8. Remote Patient Monitoring
4.8.1. Remote Patient Monitoring market, 2018 - 2030 (USD Million)
4.9. Population Health Management
4.9.1. Population Health Management market, 2018 - 2030 (USD Million)
4.10. Appointment and Medication Reminders
4.10.1. Appointment and Medication Reminders market, 2018 - 2030 (USD Million)
4.11. Others
4.11.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: DELIVERY TYPE ESTIMATES & TREND ANALYSIS
5.1. U.S. Patient Engagement Solutions Market: Delivery Type Movement Analysis
5.2. U.S. Patient Engagement Solutions Market: Delivery Type Segment Dashboard
5.3. Delivery Type Movement & Market Share Analysis, 2024 & 2030
5.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Delivery Type
5.5. Web/Cloud-Based
5.5.1. Web/cloud-based market, 2018 - 2030 (USD Million)
5.6. On-premise
5.6.1. On-premise market, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: FUNCTIONALITY ESTIMATES & TREND ANALYSIS
6.1. U.S. Patient Engagement Solutions Market: Functionality Movement Analysis
6.2. U.S. Patient Engagement Solutions Market: Functionality Segment Dashboard
6.3. Functionality Movement & Market Share Analysis, 2024 & 2030
6.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Functionality
6.5. Enhanced Communication
6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.6. Patient Education
6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.7. Predictive Analysis
6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.8. Streamlined Operations
6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
6.9. Others
6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. U.S. Patient Engagement Solutions Market: End Use Movement Analysis
7.2. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
7.3. End Use Movement & Market Share Analysis, 2024 & 2030
7.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by End Use
7.5. Healthcare Providers
7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.5.2. Outpatient Facility
7.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.5.3. Inpatient Facility
7.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6. Healthcare Payers
7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6.2. Private
7.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.6.3. Public
7.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.7. Pharmaceutical Companies (Pharma)
7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8. Pharmacy
7.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.2. Independent Pharmacies (Nuclear Pharmacies)
7.8.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.3. Community Pharmacies
7.8.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.4. Mail-Order Pharmacies
7.8.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.5. Retail Pharmacies
7.8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.6. Digital Pharmacies
7.8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.7. Specialty Pharmacies
7.8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.8. Central Fill Pharmacies
7.8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.9. Compounding Pharmacies
7.8.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
7.8.10. Others (Alternate dispensing site, Closed door)
7.8.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company Categorization
8.2. Company Market Position Analysis
8.3. Company Share Analysis
8.3.1. Partnership/Collaboration/Alliance
8.3.2. New Service Launch
8.3.3. Mergers & Acquisitions
8.3.4. Others
8.4. Company Profiles/Listing
8.4.1. Cerner Corporation (Oracle)
8.4.1.1. Overview
8.4.1.2. Financial performance
8.4.1.3. Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. NextGen Healthcare, Inc.
8.4.2.1. Overview
8.4.2.2. Financial performance
8.4.2.3. Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Epic Systems Corporation
8.4.3.1. Overview
8.4.3.2. Financial performance
8.4.3.3. Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Allscripts Healthcare, LLC
8.4.4.1. Overview
8.4.4.2. Financial performance
8.4.4.3. Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. McKesson Corporation
8.4.5.1. Overview
8.4.5.2. Financial performance
8.4.5.3. Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. ResMed
8.4.6.1. Overview
8.4.6.2. Financial performance
8.4.6.3. Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Koninklijke Philips N.V.
8.4.7.1. Overview
8.4.7.2. Financial performance
8.4.7.3. Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Klara Technologies, Inc.
8.4.8.1. Overview
8.4.8.2. Financial performance
8.4.8.3. Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. CPSI, Ltd.
8.4.9.1. Overview
8.4.9.2. Financial performance
8.4.9.3. Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Experian Information Solutions, Inc.
8.4.10.1. Overview
8.4.10.2. Financial performance
8.4.10.3. Service benchmarking
8.4.10.4. Strategic initiatives
8.4.11. athenahealth
8.4.11.1. Overview
8.4.11.2. Financial performance
8.4.11.3. Service benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Solutionreach, Inc.
8.4.12.1. Overview
8.4.12.2. Financial performance
8.4.12.3. Service benchmarking
8.4.12.4. Strategic initiatives
8.4.13. IBM
8.4.13.1. Overview
8.4.13.2. Financial performance
8.4.13.3. Service benchmarking
8.4.13.4. Strategic initiatives
8.4.14. MEDHOST
8.4.14.1. Overview
8.4.14.2. Financial performance
8.4.14.3. Service benchmarking
8.4.14.4. Strategic initiatives
8.4.15. Nuance Communications, Inc.
8.4.15.1. Overview
8.4.15.2. Financial performance
8.4.15.3. Service benchmarking
8.4.15.4. Strategic initiatives
